Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation
Xinhua Chen, Zean Zhao, Jiajun Luo, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105444-105444
Closed Access | Times Cited: 14

Showing 14 citing articles:

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 29
Gut microecology: effective targets for natural products to modulate uric acid metabolism
Hui Wang, Yixuan Zheng, Mengfan Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity
Zean Zhao, Jian Luo, Hui Liao, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106405-106405
Closed Access | Times Cited: 19
A promising strategy for assessing the uricosuric effect of anti-hyperuricemia candidates: a case study of caffeoylquinic acids extract of Artemisia selengensis Turcz. leaves
Xiang Lin, Mohammed Mansour, Yuting Huang, et al.
Food, Nutrition and Health. (2025) Vol. 2, Iss. 1
Open Access
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107381-107381
Closed Access | Times Cited: 4
Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
Jiajun Luo, Xinhua Chen, Peng-ying Liang, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106637-106637
Open Access | Times Cited: 10
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
Zihan Hou, Aijinxiu Ma, Jiale Mao, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 895-909
Closed Access | Times Cited: 9
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents
Zean Zhao, Jin Liu, L. Yuan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114682-114682
Closed Access | Times Cited: 10
Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1
Fujita Kazuki, Noriyoshi Isozumi, Qiunan Zhu, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 390, Iss. 1, pp. 99-107
Open Access | Times Cited: 1
A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
Qianghua Yuan, Yuan Cheng, Rong Sheng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 7
Development and Validation of a Novel Fluorescence-Based Hk-2 Cell Model for Assessing Uricosuric Effects: Application to Artemisia Selengensis Turcz. Leaves
Xiang Lin, Mohammed Mansour, Yuting Huang, et al.
(2024)
Closed Access
Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents
Zean Zhao, Xinhua Chen, Jiajun Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116753-116753
Closed Access
Identification of N-phenyl-N-(quinolin-4-yl) amino carboxylic acids as URAT1 inhibitors with hypouricemic effects
Xianxin Hou, Mengjie Shao, Lei Zhang, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130053-130053
Closed Access
Tinospora crispa (L.) Hook.f. & Thomson vines ameliorates hyperuricemia by inhibiting synthesis and promoting excretion of uric acid through targeting NLRP3/caspase-1/IL-1β pathway
N. Chen, Dandan Liu, Zhonghu He, et al.
Journal of Ethnopharmacology (2024), pp. 119271-119271
Closed Access
Page 1

Scroll to top